vs
合众银行（FSBC）与SOLENO THERAPEUTICS INC（SLNO）财务数据对比。点击上方公司名可切换其他公司
SOLENO THERAPEUTICS INC的季度营收约是合众银行的1.5倍（$66.0M vs $45.1M），合众银行净利率更高（41.3% vs 39.4%，领先1.9%）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
索雷诺治疗是一家临床阶段生物制药企业，专注于开发针对罕见内分泌、代谢及神经发育疾病的创新疗法，核心在研药物用于治疗普拉德-威利综合征，服务覆盖北美、欧盟等地区的罕见病患者群体。
FSBC vs SLNO — 直观对比
营收规模更大
SLNO
是对方的1.5倍
$45.1M
净利率更高
FSBC
高出1.9%
39.4%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $66.0M |
| 净利润 | $18.6M | $26.0M |
| 毛利率 | — | 98.3% |
| 营业利润率 | — | 33.5% |
| 净利率 | 41.3% | 39.4% |
| 营收同比 | — | — |
| 净利润同比 | 42.0% | 134.0% |
| 每股收益（稀释后） | $0.87 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCSLNO
| Q1 26 | $45.1M | — | ||
| Q4 25 | $43.5M | — | ||
| Q3 25 | $41.3M | $66.0M | ||
| Q2 25 | $38.3M | $32.7M | ||
| Q1 25 | $35.3M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $31.8M | — | ||
| Q2 24 | $30.7M | — |
净利润FSBCSLNO
| Q1 26 | $18.6M | — | ||
| Q4 25 | $17.6M | — | ||
| Q3 25 | $16.3M | $26.0M | ||
| Q2 25 | $14.5M | $-4.7M | ||
| Q1 25 | $13.1M | — | ||
| Q4 24 | $13.3M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — |
毛利率FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 53.8% | 33.5% | ||
| Q2 25 | 52.4% | -20.0% | ||
| Q1 25 | 52.0% | — | ||
| Q4 24 | 55.1% | — | ||
| Q3 24 | 48.0% | — | ||
| Q2 24 | 49.4% | — |
净利率FSBCSLNO
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.6% | — | ||
| Q3 25 | 39.6% | 39.4% | ||
| Q2 25 | 37.9% | -14.4% | ||
| Q1 25 | 37.1% | — | ||
| Q4 24 | 37.9% | — | ||
| Q3 24 | 34.4% | — | ||
| Q2 24 | 35.2% | — |
每股收益（稀释后）FSBCSLNO
| Q1 26 | $0.87 | — | ||
| Q4 25 | $0.83 | — | ||
| Q3 25 | $0.77 | $0.47 | ||
| Q2 25 | $0.68 | $-0.09 | ||
| Q1 25 | $0.62 | — | ||
| Q4 24 | $0.61 | — | ||
| Q3 24 | $0.52 | — | ||
| Q2 24 | $0.51 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $498.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $458.5M | $494.8M |
| 总资产 | $5.0B | $599.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSBCSLNO
| Q1 26 | $644.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FSBCSLNO
| Q1 26 | $458.5M | — | ||
| Q4 25 | $445.8M | — | ||
| Q3 25 | $431.3M | $494.8M | ||
| Q2 25 | $416.7M | $240.1M | ||
| Q1 25 | $406.5M | — | ||
| Q4 24 | $396.6M | — | ||
| Q3 24 | $389.9M | — | ||
| Q2 24 | $380.5M | — |
总资产FSBCSLNO
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.8B | — | ||
| Q3 25 | $4.6B | $599.9M | ||
| Q2 25 | $4.4B | $332.3M | ||
| Q1 25 | $4.2B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.6B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $43.5M |
| 自由现金流经营现金流 - 资本支出 | — | $43.5M |
| 自由现金流率自由现金流/营收 | — | 65.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | $72.6M | — | ||
| Q3 25 | $18.8M | $43.5M | ||
| Q2 25 | $17.8M | $-12.6M | ||
| Q1 25 | $15.5M | — | ||
| Q4 24 | $51.8M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $16.0M | — |
自由现金流FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | $71.4M | — | ||
| Q3 25 | $18.6M | $43.5M | ||
| Q2 25 | $17.5M | $-12.6M | ||
| Q1 25 | $15.4M | — | ||
| Q4 24 | $51.2M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $15.8M | — |
自由现金流率FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | 164.3% | — | ||
| Q3 25 | 45.0% | 65.8% | ||
| Q2 25 | 45.8% | -38.6% | ||
| Q1 25 | 43.5% | — | ||
| Q4 24 | 145.5% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 51.6% | — |
资本支出强度FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — |
现金转化率FSBCSLNO
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.15× | 1.67× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 3.89× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
SLNO
暂无分部数据
